Form 4: Bioventus Inc. SVP & CFO Mark Leonard Singleton Reports Stock Transaction
SEC Form 4 Filing
Mark Leonard Singleton, SVP & CFO of Bioventus Inc., reports the vesting of restricted stock units and subsequent acquisition of Class A Common Stock on March 21, 2025.
Summary
- On March 21, 2025, Mark Leonard Singleton, the SVP & CFO of Bioventus Inc., reported a transaction involving Class A Common Stock.
- Singleton acquired 18,625 shares of Class A Common Stock upon the vesting of restricted stock units (RSUs).
- The transaction was executed under Transaction Code M, indicating the exercise or conversion of a derivative security.
- Following the transaction, Singleton directly owns 137,442 shares of Class A Common Stock.
- Singleton also directly owns 18,625 derivative securities (Restricted Stock Units).
Sentiment
Score: 5
Explanation: This is a routine regulatory filing reflecting scheduled vesting of stock options, so it's neutral in sentiment.
Industry Context
This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency to investors regarding insider transactions.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding executive compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| 03/21/2023 | Start date of the four approximately equal annual installments for the vesting of 74,500 RSUs. |
| 03/21/2025 | Date of transaction: vesting of 18,625 Restricted Stock Units and acquisition of Class A Common Stock. |
Keywords
Form 4, Bioventus Inc., BVS, Mark Leonard Singleton, SVP & CFO, Class A Common Stock, Restricted Stock Units, RSU, Beneficial Ownership, Securities Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.